CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Interferon-BetaWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)

Name (Synonyms) Correlation
drug838 The Vie Scope laryngoscope Wiki 1.00
drug839 The standard Macintosh laryngoscope Wiki 1.00
drug358 Hydoxychloroquine or Chloroquine Wiki 1.00
drug82 Azithromycin Wiki 0.21

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.07
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial

ACT is a randomized clinical trial to assess therapies to reduce the clinical progression of COVID-19.

NCT04324463 Coronavirus Severe Acute Respiratory Syndrome Drug: Azithromycin Drug: Hydoxychloroquine or Chloroquine Drug: Interferon-Beta
MeSH:Coronavirus Infections Severe Acute Respiratory Syndrome

Primary Outcomes

Description: In outpatients with COVID-19, the occurrence of hospital admission or death

Measure: Outpatients: Hospital Admission or Death

Time: Up to 6 weeks post randomization

Description: Patients intubated or requiring imminent intubation at the time of randomization will only be followed for the primary outcome of death.

Measure: Inpatients: Invasive mechanical ventilation or mortality

Time: Up to 6 weeks post randomization

No related HPO nodes (Using clinical trials)